Screener
MiMedx Group MDXG Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $62.28M-45.2% | $64.36M-34.7% | $58.99M-33.1% | $118.1M+27.1% | $113.73M+35.3% | ||
| $12.58M-32.8% | $19.98M+7.0% | $17.37M+4.9% | $19.06M+12.7% | $18.72M+22.2% | ||
| $49.7M-47.7% | $44.38M-44.5% | $41.62M-41.9% | $99.04M+30.3% | $95.01M+38.2% | ||
| 79.8%-3.7pp | 69%-12.1pp | 70.6%-10.7pp | 83.9%+2.1pp | 83.5%+1.8pp | ||
| $2.8M-24.5% | $2.78M-15.9% | $4.14M+24.4% | $4.76M+33.3% | $3.7M+26.9% | ||
| $58.31M-15.5% | $59.78M-6.8% | $53.23M-11.2% | $73.07M+19.7% | $69M+28.9% | ||
| -$11.7M-153% | -$18.47M-249% | -$16.05M-295% | $21.08M+90.7% | $22.19M+98.8% | ||
| -18.8%-38.3pp | -28.7%-41.2pp | -27.2%-36.6pp | 17.8%+5.9pp | 19.5%+6.2pp | ||
| $776K-1.1% | $788K+6.8% | $886K+75.1% | $904K— | $785K+182% | ||
| -$136K-7.9% | -$102K-1.0% | -$168K-15.9% | -$186K+10.6% | -$126K-500% | ||
| -$11.06M-148% | -$17.78M-237% | -$15.33M-278% | $21.8M+93.8% | $22.85M+100% | ||
| -$2.38M-139% | -$2.94M-187% | -$4.47M-381% | $6.6M+73.3% | $6.1M+72.3% | ||
| -$8.68M-152% | -$14.84M-254% | -$10.86M-255% | $15.19M+104% | $16.75M+107% | ||
| -13.9%-28.7pp | -23.1%-32.8pp | -18.4%-26.4pp | 12.9%+4.9pp | 14.7%+5.1pp | ||
| -$0.06-155% | -$0.10-267% | -$0.07-240% | $0.10+100.0% | $0.11+120% | ||
| -$11.41M-144% | -$18.18M-213% | -$15.75M-232% | $24.8M+97.4% | $25.91M+104% | ||
| -18.3%-41.1pp | -28.2%-44.6pp | -26.7%-40.3pp | 21%+7.5pp | 22.8%+7.7pp | ||
| -$11.7M-153% | -$18.47M-249% | -$16.05M-295% | $21.08M+90.7% | $22.19M+98.8% |
FAQ
- What is MiMedx Group's revenue?
- MiMedx Group (MDXG) generated $303.7M in revenue over the trailing twelve months, down 22.8% year over year.
- Is MiMedx Group profitable?
- MiMedx Group is not currently profitable: it reported a net loss of $19.2M over the trailing twelve months, a -6.3% net margin.
- What are MiMedx Group's profit margins?
- Gross margin is 77.3% and operating margin is -8.3%, with a -6.3% net margin.
- What is MiMedx Group's earnings per share?
- MiMedx Group's diluted EPS over the trailing twelve months is $-0.13.
- Where does MiMedx Group's income statement data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
